- Investing Ideas
- /
- Global Pharmaceuticals & Biotech High Return On Equity, Low Debt
Global Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
44
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
44 companies
Pharmedic Pharmaceutical Medicinal
Market Cap: ₫1.6t
Engages in the manufacture and trade of pharmaceutical products, medicinal materials, cosmetics, medical supplies, and other products in Vietnam.
PMC
₫169,200.00
7D
17.7%
1Y
65.6%
Arab Drug
Market Cap: ج.م2.6b
Engages in the manufacture and sale of pharmaceutical products.
ADCI
ج.م219.47
7D
1.3%
1Y
325.3%
JW Shinyak
Market Cap: ₩75.4b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩1,385.00
7D
-0.4%
1Y
-0.9%
Influx Healthtech
Market Cap: ₹4.6b
Operates as a contract development and manufacturing organization that provides a range of healthcare products in India.
INFLUX
₹198.05
7D
9.2%
1Y
n/a
Genesis IBRC India
Market Cap: ₹2.3b
Does not have significant operations.
514336
₹177.75
7D
8.2%
1Y
1,021.5%
Simply Solventless Concentrates
Market Cap: CA$24.3m
Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada.
HASH
CA$0.21
7D
-10.6%
1Y
-65.0%
Asston Pharmaceuticals
Market Cap: ₹661.4m
Manufactures pharmaceutical products in India, West Africa, South Africa, and Asian countries.
544445
₹77.69
7D
-6.5%
1Y
n/a
Accretion Pharmaceuticals
Market Cap: ₹613.0m
Engages in the manufacturing and marketing of pharmaceutical products in India.
ACCPL
₹57.20
7D
-4.5%
1Y
n/a